3 ms·
Yes, but this isnt as negative as it sounds. That 2 months average is often driven by more people alive at the end of a 2 year trial. Also, 16 years of 2 mont
by s1artibartfast 3y ago
Yes, but this isnt as negative as it sounds.
That 2 months average is often driven by more people alive at the end of a 2 year trial.
Also, 16 years of 2 month extensions ends up being quite meaningful.
- pauln99 3y agoTo be clear, those aren't 16 years of accumulating improvements. The median life extension - across all 90-odd drugs - was two months.
- s1artibartfast 3y agoI understand that specifically is for stage 4 non small cell lung cancer, but I don't think it's appropriate to cherry pick a single example. There are other cancers and stages we're much more progress has been made.